📈 stocks · US

ARMP

Armata Pharmaceuticals
stocks US
Overall assessment · Trend now + news, 30 days ?
▲ Strongly bullish strong Confidence 45 % ?
News situation · 1 items / 30 D
▲ Bullish strong 45 %
5.0 Impact / 10
By source type
Release 1

1 of 1 straight from the issuer or regulator

News, 30 days
Bullish
Signal history

Both worlds over time

Technical and news signals of the last 30 days on one timeline.

Bullish ▲Bearish ▼07.10. · News signal · Impact 5/10
30 days ago today
Technical signal News signal Size = strength
News, 30 days

What is being reported about ARMP

Asset Snapshot

📝 Overview Generated automatically?

ARMP has been the subject of 1 signals across 1 articles in the last 365 days. Sentiment skews Bullish (100%).

Breakdown: 1 bullish, 0 bearish, 0 neutral. AI confidence averages 60% across all signals.

Most-cited catalysts: Issuance of two US patents for clinical candidates AP-SA02 and AP-PA02 (1×), Extension of intellectual property protection until at least 2041 (1×). Most-cited risk factors: Failure of clinical candidates to meet primary endpoints in late-stage trials (1×), Inability to commercialize products before patent expiration (1×).